FDA Drug Application (021515) for WELLBUTRIN XL by VALEANT INTL

Back to FDA Applications sponsored by VALEANT INTL

Application Number021515
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameWELLBUTRIN XL
Active IngredientBUPROPION HYDROCHLORIDE



Back to FDA Applications sponsored by VALEANT INTL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.